E-LIB Suche - Ergebnisse für: Pulido, Marina

1

Impact of metronomic trabectedin combined with low-dose cyc..:

Sun, Cheng-Ming ; Toulmonde, Maud ; Spalato-Ceruso, Mariella...
Molecular Cancer. 23 (2024) 1 - p. , 2024

2

Pembrolizumab combined with low-dose cyclophosphamide and i..:

Spalato-Ceruso, Mariella ; Bouteiller, Fanny ; Guegan, Jean-Philippe...
Journal of Hematology & Oncology. 15 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

3

Diffusion-weighted MRI and PET/CT reproducibility in epithe..:

Crombé, Amandine ; Gauquelin, Lisa ; Nougaret, Stéphanie...
Diagnostic and Interventional Imaging. 102 (2021) 10 - p. 629-639 , 2021

Link: https://doi.org/10.1016/..

4

Predictive factors of 5-year relapse-free survival in HR+/H..:

Lerebours, Florence ; Pulido, Marina ; Fourme, Emmanuelle...
British Journal of Cancer. 122 (2020) 6 - p. 759-765 , 2020

Link: https://doi.org/10.1038/..

5

Pazopanib or methotrexate–vinblastine combination chemother..:

Toulmonde, Maud ; Pulido, Marina ; Ray-Coquard, Isabelle...
The Lancet Oncology. 20 (2019) 9 - p. 1263-1272 , 2019

Link: https://doi.org/10.1016/..

6

Safety and efficacy of temsirolimus as second line treatmen..:

Pulido, Marina ; Roubaud, Guilhem ; Cazeau, Anne-Laure...
BMC Cancer. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

7

Clinical and genomic analysis of a randomised phase II stud..:

Quenel-Tueux, Nathalie ; Debled, Marc ; Rudewicz, Justine...
British Journal of Cancer. 113 (2015) 4 - p. 585-594 , 2015

Link: https://doi.org/10.1038/..

8

FOLFIRI® and Bevacizumab in first-line treatment for colore..:

Bécouarn, Yves ; Cany, Laurent ; Pulido, Marina...
BMC Research Notes. 7 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

9

A Phase II Trial Evaluating the Efficacy and Safety of Efav..:

Houédé, Nadine ; Pulido, Marina ; Mourey, Loic...
The Oncologist. 19 (2014) 12 - p. 1227-1228 , 2014

Link: https://doi.org/10.1634/..

10

Protocol of the Definition for the Assessment of Time-to-ev..:

Bellera, Carine A. ; Pulido, Marina ; Gourgou, Sophie...
European Journal of Cancer. 49 (2013) 4 - p. 769-781 , 2013

Link: https://doi.org/10.1016/..

11

Diagnostic accuracy of 18F-FDG PET/CT for assessing respons..:

Bonichon, Françoise ; Palussière, Jean ; Godbert, Yann...
European Journal of Nuclear Medicine and Molecular Imaging. 40 (2013) 12 - p. 1817-1827 , 2013

Link: https://doi.org/10.1007/..

12

Role of DNA Repair Gene Polymorphisms in the Efficiency of ..:

Mathiaux, Juliette ; Le Morvan, Valérie ; Pulido, Marina...
Molecular Diagnosis & Therapy. 15 (2011) 3 - p. 159-166 , 2011

Link: https://doi.org/10.1007/..

13

Heterogeneity of SOS response expression in clinical isolat..:

Diaz-Diaz, Sara ; Garcia-Montaner, Andrea ; Vanni, Roberta...
Drug Resistance Updates. 75 (2024) - p. 101087 , 2024

Link: https://doi.org/10.1016/..

14

Genetic features of BEL-1-producing and KPC-2-producing E. ..:

Romero-Oraá, Laura ; Pulido, Marina R. ; Galán, Fatima...
Environmental Science and Pollution Research. 31 (2024) 31 - p. 43896-43902 , 2024

Link: https://doi.org/10.1007/..

15

RecA inactivation as a strategy to reverse the heteroresist..:

Diaz-Diaz, S. ; Yerbes, Pilar ; Recacha, E....
International Journal of Antimicrobial Agents. 61 (2023) 2 - p. 106721 , 2023

Link: https://doi.org/10.1016/..